Congratulations to our incoming residents on Match Day! We are thrilled to welcome this talented group to the Penn Radiology family and can’t wait for you to begin your journey with us.
#PennRadiology#Match2026#MatchDay#RadRes
I’m so grateful to @Penn_IR and @PennRadiology for the incredible research and clinical opportunities as a med student. Special thanks to @AVanceIR and Dr. Timothy Clark—watching them save lives and limbs in the IR suite is what sold me on this amazing specialty!
Join us in welcoming the newest members of our Diagnostic Radiology and IR Integrated Residency programs! Get ready to embark on an incredible journey of life, learning, innovation, and excellence. Welcome to the Penn family! #PennRadiology#FutureLeaders#Match2025#RadRes
Excited to share our publication on #NLP of #radiology reports with @ysu1213! Grateful to @cekahn for his incredible mentorship—this was an invaluable learning experience. #LLMs#negex
https://t.co/7wIYPcF9FR
Our multidisciplinary team achieved a 2-yr freedom from major amputation of 97.4% among R4-6 CLI patients without ESRD following index PVI. The downside-among matched cohort with ESRD major amputation risk was 7-times higher. #CLIflighters@SIRspecialists
https://t.co/AI1CWXtZJ0
5/6 📘 Conclusion: ESRD is a strong predictor of MALE & major amputation in patients undergoing PVI for Rutherford 4-6 CLI.
More vigilant monitoring & innovative methods are essential.
Link to abstract: https://t.co/d5icio3Pv5
#CriticalLimbIschemia#CLI#Amputation
1/6 📢 New research published in @JVIRmedia !
Exploring the impact of end-stage renal disease (ESRD) on major adverse limb events (MALE) post percutaneous vascular intervention (PVI) in patients with Rutherford 4-6 critical limb ischemia (CLI).
#VascularIntervention#ESRD#CLI
End-stage renal disease (#ESRD) is strongly associated with below-knee #amputation as well as other major adverse limb events, according to research presented at the @SIRspecialists 2023 conference (Phoenix, USA).
#renaldisease#eskd
https://t.co/rz8xp078W5